Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ECTRIMS 2015: MEDI-551 is safe in multiple sclerosis patients; phase I results

Oct. 9, 2015

Cell culture-derived influenza vaccine shows excellent immunogenicity

Oct. 9, 2015

CMV vaccine elicits humoral and cellular immune responses in animal models

Oct. 9, 2015

Novel multiple ligand trap increases muscle and bone mass

Oct. 9, 2015

Indoximod/ipilimumab combination therapy well tolerated in phase Ib study

Oct. 9, 2015

Mixed Hantaan/Puumala virus DNA vaccine shows safety and immunogenicity

Oct. 9, 2015

Novel insulin mutation linked to autosomal dominant diabetes

Oct. 8, 2015

PTP1B shows promise for the improvement of islet graft revascularization

Oct. 8, 2015

Vitamin B12 deficiency linked to diabetic cardiovascular autonomic neuropathy

Oct. 7, 2015

Novel DYM mutations related to rare Dyggve-Melchior-Clausen syndrome

Oct. 7, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...